SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007500
Filing Date
2019-08-07
Accepted
2019-08-07 16:48:20
Documents
64
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20190630x10q.htm   iXBRL 10-Q 1256626
2 EX-10.1 imgn-20190630ex1015e08d4.htm EX-10.1 145763
3 EX-31.1 imgn-20190630ex311db3ebf.htm EX-31.1 11579
4 EX-32 imgn-20190630xex32.htm EX-32 7831
  Complete submission text file 0001558370-19-007500.txt   6718482

Data Files

Seq Description Document Type Size
5 EX-101.SCH imgn-20190630.xsd EX-101.SCH 54561
6 EX-101.CAL imgn-20190630_cal.xml EX-101.CAL 41486
7 EX-101.DEF imgn-20190630_def.xml EX-101.DEF 216305
8 EX-101.LAB imgn-20190630_lab.xml EX-101.LAB 510503
9 EX-101.PRE imgn-20190630_pre.xml EX-101.PRE 384040
10 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20190630x10q_htm.xml XML 1198818
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 191006158
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences